Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2019.4748
Abstract: Importance For patients awaiting heart transplant, hepatitis C-positive donors offer an opportunity to expand the donor pool, shorten wait times, and decrease wait-list mortality. While early reported outcomes among few heart transplant recipients have been… read more here.
Keywords: hepatitis; transplant; direct acting; heart transplant ... See more keywords
Hepatitis E Virus and Guillain-Barré Syndrome.
Sign Up to like & getrecommendations! Published in 2017 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2016.3651
Abstract: A century ago when Guillain, Barré, and Strohl described the acute inflammatory polyneuropathic syndrome (GuillainBarré syndrome [GBS]) for which they are still eponymously remembered, they noted that, “The pathogenesis of this radiculoneuropathic syndrome cannot be… read more here.
Keywords: hepatitis; hepatitis virus; infection; hev infection ... See more keywords
Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32129
Abstract: In the United States, incidence and mortality rates of hepatocellular carcinoma (HCC) are increasing in older individuals. Chronic infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) are important causes of HCC; however,… read more here.
Keywords: incidence; hepatocellular carcinoma; older americans; hepatitis ... See more keywords
Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28917
Abstract: The presence of an association between chronic hepatitis B virus (HBV) infection and fatty liver is controversial. We examined the association between HBV infection and the development of nonalcoholic fatty liver disease (NAFLD). We conducted… read more here.
Keywords: fatty liver; hepatitis; infection; cohort ... See more keywords
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29009
Abstract: Liver fibrosis is the net result of dynamic changes between fibrogenesis and fibrolysis. Evidence has shown that antiviral therapy can reverse liver fibrosis or even early cirrhosis caused by hepatitis B virus. However, current evaluation… read more here.
Keywords: classification; fibrosis; hepatitis; new classification ... See more keywords
Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29135
Abstract: Reactivation of hepatitis B virus (HBV) has been reported in hepatitis C virus–infected individuals receiving direct‐acting antiviral (DAA) therapy. The overall risk among patients with current or prior HBV infection in the context of DAA… read more here.
Keywords: hepatitis; daa; hbv reactivation; reactivation ... See more keywords
Autoimmune‐like chronic hepatitis induced by olmesartan
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29228
Abstract: Drug liver-induced injury (DILI) attributed to minocyclin, alpha methyldopa, or nitrofurantoin may be responsible for chronic liver damage that mimics the biological and/or histological features of chronic autoimmune hepatitis and, in rare cases, progresses to… read more here.
Keywords: induced olmesartan; like chronic; hepatitis; autoimmune like ... See more keywords
Less can be more: A finite treatment approach for HBeAg‐negative chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.29821
Abstract: Long-term administration of potent nucleos (t)ide analogs (NAs) is the cornerstone of antiviral therapy for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B, as it reduces liver-related complications by efficiently suppressing viral replication. Although there… read more here.
Keywords: hepatitis; hbeag negative; relapse; negative chronic ... See more keywords
Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.29874
Abstract: The significance of hepatitis B e‐antigen (HBeAg) seroclearance (ESC) in the long term is not well defined. The current study aimed to determine the clinical outcomes, the factors and predictive scores for hepatocellular carcinoma (HCC),… read more here.
Keywords: hepatitis; esc; antigen; predictive scores ... See more keywords
Recommendations for the Evaluation for Autoimmune Liver Disease in Nonalcoholic Fatty Liver Disease
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30057
Abstract: We read with interest the article published by Chalisani et al.(1) These Guidelines provide clarity for the diagnosis and management of NAFLD. However, we feel that routine diagnosis of nonalcoholic fatty liver disease (NAFLD) can… read more here.
Keywords: liver function; fatty liver; hepatitis; disease ... See more keywords
Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30123
Abstract: Currently, there are no interferon‐free treatments available for hepatitis C virus (HCV)–infected patients younger than 12 years. We evaluated the safety and effectiveness of the all‐oral regimen ledipasvir–sofosbuvir ± ribavirin in HCV‐infected children aged 6… read more here.
Keywords: hepatitis; hcv; safety; sofosbuvir ... See more keywords